- Home
- INSE vs HURA Comparison
INSE vs HURA Comparison
Compare INSE & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- HURA
- Stock Information
- Founded
- INSE N/A
- HURA 2009
- Country
- INSE United States
- HURA United States
- Employees
- INSE N/A
- HURA N/A
- Industry
- INSE Computer Software: Prepackaged Software
- HURA
- Sector
- INSE Technology
- HURA
- Exchange
- INSE Nasdaq
- HURA Nasdaq
- Market Cap
- INSE 273.8M
- HURA 246.9M
- IPO Year
- INSE N/A
- HURA N/A
- Fundamental
- Price
- INSE $10.98
- HURA $3.33
- Analyst Decision
- INSE Buy
- HURA Strong Buy
- Analyst Count
- INSE 5
- HURA 1
- Target Price
- INSE $14.60
- HURA $11.00
- AVG Volume (30 Days)
- INSE 170.6K
- HURA 216.5K
- Earning Date
- INSE 04-14-2025
- HURA 03-04-2025
- Dividend Yield
- INSE N/A
- HURA N/A
- EPS Growth
- INSE N/A
- HURA N/A
- EPS
- INSE N/A
- HURA N/A
- Revenue
- INSE $297,900,000.00
- HURA N/A
- Revenue This Year
- INSE N/A
- HURA N/A
- Revenue Next Year
- INSE $4.21
- HURA N/A
- P/E Ratio
- INSE N/A
- HURA N/A
- Revenue Growth
- INSE N/A
- HURA N/A
- 52 Week Low
- INSE $7.51
- HURA $2.84
- 52 Week High
- INSE $11.61
- HURA $14.60
- Technical
- Relative Strength Index (RSI)
- INSE 65.46
- HURA N/A
- Support Level
- INSE $10.83
- HURA N/A
- Resistance Level
- INSE $11.61
- HURA N/A
- Average True Range (ATR)
- INSE 0.40
- HURA 0.00
- MACD
- INSE 0.06
- HURA 0.00
- Stochastic Oscillator
- INSE 64.20
- HURA 0.00
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.